[Federal Register Volume 68, Number 118 (Thursday, June 19, 2003)]
[Notices]
[Pages 36843-36844]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-15535]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Sec.  1301.33(a) of title 21 of the Code of Federal 
Regulations (CFR), this is notice that on--January 28, 2003, CellTech 
Manufacturing CA., Inc., 3501 West Garry Avenue, Santa Ana, California 
92704, made application by renewal to the Drug Enforcement 
Administration by renewal to the Drug Enforcement Administration (DEA) 
for registration as a bulk manufacturer of Methylphenidate (1724), a 
basic class of controlled substances listed in Schedule II.
    The firm plans to manufacture the listed controlled substance to 
make finished dosage forms for distribution to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention:

[[Page 36844]]

Federal Register Representative, Office of Chief Counsel (CCD) and must 
be filed no later than August 18, 2003.

    Dated: June 6, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-15535 Filed 6-18-03; 8:45 am]
BILLING CODE 4410-09-M